The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Clinical characteristics and outcomes in renal transplant recipients with renal cell carcinoma in the native kidney

  • Sun, In O (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Ko, Yu Mi (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Kim, Eun Young (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Park, Kyung Seon (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Jung, Hong Soon (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Ko, Sun Hye (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Chung, Byung Ha (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Choi, Bum Soon (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Park, Cheol Whee (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Kim, Yong Soo (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine) ;
  • Yang, Chul Woo (Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea College of Medicine)
  • Published : 2013.05.01
⟨ Previous Next ⟩

Abstract

Background/Aims: We investigated the incidence and clinical characteristics of renal cell carcinoma (RCC) in the native kidney of renal transplant recipients. Methods: Between 1991 and 2010, 1,425 patients underwent kidney transplantation at our institution. We retrospectively evaluated the clinical features and outcomes in renal transplant patients with RCC in the native kidney after renal transplantation. Results: The patients included three males and two females with a mean age of 63 years (range, 52 to 74). The incidence of RCC was 0.35%. The median interval between renal transplantation and RCC occurrence was 16.2 years (range, 9 to 20). All of our patients with RCC had developed renal cysts either before (n = 3) or after (n = 2) renal transplantation. The mean duration of dialysis was 12 months (range, 2 to 39). Of the five patients, four underwent dialysis treatment for less than 8 months. All the RCCs were low grade at the time of diagnosis. Four patients underwent radical nephrectomy, and one patient refused the operation. The four patients who underwent radical nephrectomy showed no evidence of local recurrence or distant metastasis during the median follow-up of 2.9 years. However, the patient who did not undergo surgery developed spinal metastasis from the RCC 6 years later. Conclusions: This study suggests that the follow-up period is an important factor for the development of RCC in renal transplant recipients, and more vigorous screening with a longer follow-up period is required in renal transplant recipients.

Keywords

References

  1. Briggs JD. Causes of death after renal transplantation. Nephrol Dial Transplant 2001;16:1545-1549. https://doi.org/10.1093/ndt/16.8.1545
  2. Penn I. Second malignant neoplasms associated with immunosuppressive medications. Cancer 1976;37(2 Suppl):1024-1032. https://doi.org/10.1002/1097-0142(197602)37:2+<1024::AID-CNCR2820370806>3.0.CO;2-V
  3. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000;355:1886-1887. https://doi.org/10.1016/S0140-6736(00)02298-4
  4. Stewart JH, Buccianti G, Agodoa L, et al. Cancers of the kidney and urinary tract in patients on dialysis for endstage renal disease: analysis of data from the United States, Europe, and Australia and New Zealand. J Am Soc Nephrol 2003;14:197-207. https://doi.org/10.1097/01.ASN.0000039608.81046.81
  5. Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am J Transplant 2004;4:905-913. https://doi.org/10.1111/j.1600-6143.2004.00450.x
  6. Goh A, Vathsala A. Native renal cysts and dialysis duration are risk factors for renal cell carcinoma in renal transplant recipients. Am J Transplant 2011;11:86-92. https://doi.org/10.1111/j.1600-6143.2010.03303.x
  7. Ishikawa I, Saito Y, Shikura N, Kitada H, Shinoda A, Suzuki S. Ten-year prospective study on the development of renal cell carcinoma in dialysis patients. Am J Kidney Dis 1990;16:452-458. https://doi.org/10.1016/S0272-6386(12)80058-8
  8. Levine E, Slusher SL, Grantham JJ, Wetzel LH. Natural history of acquired renal cystic disease in dialysis patients: a prospective longitudinal CT study. AJR Am J Roentgenol 1991;156:501-506. https://doi.org/10.2214/ajr.156.3.1899744
  9. Truong LD, Krishnan B, Cao JT, Barrios R, Suki WN. Renal neoplasm in acquired cystic kidney disease. Am J Kidney Dis 1995;26:1-12. https://doi.org/10.1016/0272-6386(95)90146-9
  10. Moudouni SM, Lakmichi A, Tligui M, et al. Renal cell carcinoma of native kidney in renal transplant recipients. BJU Int 2006;98:298-302. https://doi.org/10.1111/j.1464-410X.2006.06267.x
  11. Klatte T, Seitz C, Waldert M, et al. Features and out-comes of renal cell carcinoma of native kidneys in renal transplant recipients. BJU Int 2010;105:1260-1265. https://doi.org/10.1111/j.1464-410X.2009.08941.x
  12. Ministry for Health, Welfare and Family Affairs. Annual report of cancer incidence (2007), cancer prevalence (2007), and survival (1993-2007) in Korea. Seoul: Ministry for Health, Welfare and Family Affairs, 2009.
  13. Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol 2008;179:1704-1708. https://doi.org/10.1016/j.juro.2008.01.027
  14. Hurst FP, Jindal RM, Graham LJ, et al. Incidence, predictors, costs, and outcome of renal cell carcinoma after kidney transplantation: USRDS experience. Transplantation 2010;90:898-904.
  15. Cheuk W, Lo ES, Chan AK, Chan JK. Atypical epithelial proliferations in acquired renal cystic dis ease harbor cytogenetic aberrations. Hum Pathol 2002;33:761-765. https://doi.org/10.1053/hupa.2002.125370
  16. Ishikawa I, Yuri T, Kitada H, Shinoda A. Regression of acquired cystic disease of the kidney after successful renal transplantation. Am J Nephrol 1983;3:310-314. https://doi.org/10.1159/000166738
  17. Filocamo MT, Zanazzi M, Li Marzi V, et al. Renal cell carcinoma of native kidney after renal transplantation: clinical relevance of early detection. Transplant Proc 2009;41:4197-4201. https://doi.org/10.1016/j.transproceed.2009.08.082
  18. Hwang JK, Moon IS, Kim JI. Malignancies after kidney transplantation: a 40-year single-center experience in Korea. Transpl Int 2011;24:716-721. https://doi.org/10.1111/j.1432-2277.2011.01270.x

Cited by

  1. Incidental Renal Cell Carcinoma Originating From a Native Kidney After En-bloc Resection for Adrenal Carcinoma in a Kidney Transplant Recipient vol.46, pp.2, 2013, https://doi.org/10.1016/j.transproceed.2013.11.078
  2. Advanced native-kidney carcinoma in a heart- and kidney-transplanted patient: a case report vol.7, pp.1, 2018, https://doi.org/10.1007/s13730-018-0310-9
  3. Erythrocyte glucose-6-phosphate dehydrogenase activity and risk of gestational diabetes vol.18, pp.2, 2013, https://doi.org/10.1007/s40200-019-00464-5
  4. Papillary renal cell carcinoma with sarcomatoid differentiation in a native kidney of transplant recipient: A case report and review of literature vol.31, pp.4, 2021, https://doi.org/10.4103/ijn.ijn_239_20